Automated Organization ProfileSeoul National University Seoul Metropolitan Government Boramae Medical Center
Seoul National University Seoul Metropolitan Government Boramae Medical Center
Current S-Index
Sum of Dataset Indices for all datasets
Average Dataset Index per Dataset
Average Dataset Index per dataset
Total Datasets
Total datasets in this organization
Average FAIR Score
Average FAIR Score per dataset
Total Citations
Total citations to the organization's datasets
Total Mentions
Total mentions of the organization's datasets
S-Index Interpretation
The S-Index (Sharing Index) is a comprehensive metric that represents the cumulative impact of all your datasets. It is calculated as the sum of Dataset Index scores across all your claimed datasets.
What it means:
- A higher S-index indicates greater overall impact of your datasets relative to typical datasets in their fields of research
- The S-Index grows as you add more datasets or as existing datasets gain more citations and mentions
- It provides a single number to track your research data impact over time
Current S-Index: 8.3 (sum of 6 datasets Dataset Index scores)
More information here.
S-Index Over Time
Cumulative Citations Over Time
Cumulative Mentions Over Time
Datasets
Supplemental materials of the article, "Association between biologic and nonbiologic systemic therapy for psoriasis and psoriatic arthritis and the risk of new-onset and recurrent major adverse cardiovascular events: A retrospective cohort study".1. Supplementary figure 1. A) Time to MACE for TNF-α inhibitors, nonbiologic systemic, and phototherapy in population without a history of MACE.2. Supplementary figure 1. B) Time to MACE for Non-TNF-α biologics, nonbiologic systemic, and phototherapy in population without a history of MACE.3. Supplementary figure 2. A) Time to MACE for TNF-α inhibitors, nonbiologic systemic, and phototherapy in population with a history of MACE.4. Supplementary figure 2. B) Time to MACE for Non-TNF-α biologics, nonbiologic systemic, and phototherapy in population with a history of MACE. 5. Supplementary figure 3. Risk of MACE with biologic versus nonbiologic systemic therapy according to history of MACE.6. Supplementary Table I. Demographic and clinical characteristics of patients based on history of MACE.7. Supplementary Table II. Risk of MACE with biologics (TNF-α inhibitor, non-TNF-α biologics), nonbiologic systemic therapy, and phototherapy according to MACE history in psoriasis and psoriatic arthritis.
Authors
- Song, Won Ji ;
- Yoon, Hyun-Sun ;
- Oh, Sohee
Supplemental materials of the article, "Association between biologic and nonbiologic systemic therapy for psoriasis and psoriatic arthritis and the risk of new-onset and recurrent major adverse cardiovascular events: A retrospective cohort study".1. Supplementary figure 1. A) Time to MACE for TNF-α inhibitors, nonbiologic systemic, and phototherapy in population without a history of MACE.2. Supplementary figure 1. B) Time to MACE for Non-TNF-α biologics, nonbiologic systemic, and phototherapy in population without a history of MACE.3. Supplementary figure 2. A) Time to MACE for TNF-α inhibitors, nonbiologic systemic, and phototherapy in population with a history of MACE.4. Supplementary figure 2. B) Time to MACE for Non-TNF-α biologics, nonbiologic systemic, and phototherapy in population with a history of MACE. 5. Supplementary figure 3. Risk of MACE with biologic versus nonbiologic systemic therapy according to history of MACE.6. Supplementary Table I. Demographic and clinical characteristics of patients based on history of MACE.7. Supplementary Table II. Risk of MACE with biologics (TNF-α inhibitor, non-TNF-α biologics), nonbiologic systemic therapy, and phototherapy according to MACE history in psoriasis and psoriatic arthritis.
Authors
- Song, Won Ji ;
- Yoon, Hyun-Sun ;
- Oh, Sohee
Supplementary materials for "Evaluation of efficacy and safety of non-ablative 1550-nm fractional laser for facial syringoma: A case-series study"Supplementary Figure 1. Change in PSSI scores before and after 1550-nm fractional laser treatment Supplementary Figure 2. Correlation between the number of treatment sessions and global improvement scaleSupplementary Figure 3. Correlation between the number of treatment sessions and delta PSSI
Authors
- Kim, Taemin ;
- Cho, Soyun ;
- Kwon, So young
Supplementary materials for "Evaluation of efficacy and safety of non-ablative 1550-nm fractional laser for facial syringoma: A case-series study"Supplementary Figure 1. Change in PSSI scores before and after 1550-nm fractional laser treatment Supplementary Figure 2. Correlation between the number of treatment sessions and global improvement scaleSupplementary Figure 3. Correlation between the number of treatment sessions and delta PSSI
Authors
- Kim, Taemin ;
- Cho, Soyun ;
- Kwon, So young
The STB-1400 mechanical stretching device (Strex Inc., Osaka, Japan) was used to expose cells to cyclic mechanical stretching (maximum 20% elongation, 10 cycles/min, 0.166 Hz) for 24 h, thereby mimicking the normal respiratory rate of healthy adults.
Authors
- Park, Ji-Ung
The STB-1400 mechanical stretching device (Strex Inc., Osaka, Japan) was used to expose cells to cyclic mechanical stretching (maximum 20% elongation, 10 cycles/min, 0.166 Hz) for 24 h, thereby mimicking the normal respiratory rate of healthy adults.
Authors
- Park, Ji-Ung